These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 27570420)

  • 1. Molecular mechanisms of peritoneal dissemination in gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2016 Aug; 22(30):6829-40. PubMed ID: 27570420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and biology of peritoneal carcinomatosis.
    Kusamura S; Baratti D; Zaffaroni N; Villa R; Laterza B; Balestra MR; Deraco M
    World J Gastrointest Oncol; 2010 Jan; 2(1):12-8. PubMed ID: 21160812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for peritoneal dissemination of gastric cancer.
    Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
    Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure.
    Fujii S; Kitayama J; Kaisaki S; Sasaki S; Seto Y; Tominaga O; Tsuno N; Umetani N; Yokota H; Kitamura K; Tsuruo T; Nagawa H
    J Exp Clin Cancer Res; 2002 Dec; 21(4):547-53. PubMed ID: 12636101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer cell detection in peritoneal lavage: RT-PCR for carcinoembryonic antigen transcripts versus the combined cytology with peritoneal carcinoembryonic antigen levels.
    Wang JY; Lin SR; Lu CY; Chen CC; Wu DC; Chai CY; Chen FM; Hsieh JS; Huang TJ
    Cancer Lett; 2005 Jun; 223(1):129-35. PubMed ID: 15890245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary results of prophylactic HIPEC in patients with locally advanced gastric cancer.
    Graziosi L; Cantarella F; Mingrone E; Gunnellini M; Cavazzoni E; Liberati M; Donini A
    Ann Ital Chir; 2013; 84(5):551-6. PubMed ID: 24140896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic evaluation of peritoneal lavage smears and gastric wall brushing smears in gastric cancer surgery].
    Teramoto T; Onda M; Tokunaga A; Fujita I; Shirakawa T; Takita M; Oguri T; Okuda T; Kiyama T; Yoshiyuki T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1606-9. PubMed ID: 7574771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of peritoneal washing cytology in patients with potentially resectable gastric cancer.
    Nakagohri T; Yoneyama Y; Kinoshita T; Konishi M; Inoue K; Takahashi S
    Hepatogastroenterology; 2008; 55(86-87):1913-5. PubMed ID: 19102421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer.
    Tokuda K; Natsugoe S; Nakajo A; Miyazono F; Ishigami S; Hokita S; Takao S; Eizuru Y; Aikou T
    Int J Mol Med; 2003 Jan; 11(1):79-84. PubMed ID: 12469223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy using ets-1 transcription factor decoy for peritoneal dissemination of gastric cancer.
    Taniguchi H; Fujiwara Y; Doki Y; Sugita Y; Sohma I; Miyata H; Takiguchi S; Yasuda T; Tomita N; Morishita R; Monden M
    Int J Cancer; 2007 Oct; 121(7):1609-17. PubMed ID: 17546598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway.
    Cheng TY; Wu MS; Lin JT; Lin MT; Shun CT; Huang HY; Hua KT; Kuo ML
    Cancer; 2012 Dec; 118(23):5757-67. PubMed ID: 22736399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
    Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
    Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin overexpression mediates gastric cancer peritoneal dissemination by inducing mesothelial cell senescence.
    Miao ZF; Wu JH; Wang ZN; Zhao TT; Xu HM; Song YX; Xing YN; Huang JY; Zhang JY; Liu XY; Xu H; Xu YY
    Hum Pathol; 2016 May; 51():114-23. PubMed ID: 27067789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial.
    Tamura S; Fujiwara Y; Kimura Y; Fujita J; Imamura H; Kinuta M; Yano M; Hiratsuka M; Kobayashi K; Okada K; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):75-80. PubMed ID: 24155213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal cytology in patients with gastric cancer exposed to the serosa--a proposed new classification based on the local and distant cytology.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(52):1183-6. PubMed ID: 12846010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking TGF-β1 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo.
    Lv ZD; Zhao WJ; Jin LY; Wang WJ; Dong Q; Li N; Xu HM; Wang HB
    Biomed Pharmacother; 2017 Apr; 88():27-33. PubMed ID: 28092842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated mesothelial cells are negative prognostic factors in gastric cancer and promote peritoneal dissemination of adherent gastric cancer cells by chemotaxis.
    Miao ZF; Zhao TT; Wang ZN; Miao F; Xu YY; Mao XY; Gao J; Xu HM
    Tumour Biol; 2014 Jun; 35(6):6105-11. PubMed ID: 24615523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
    Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
    Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.
    Shigeyasu K; Kagawa S; Uno F; Nishizaki M; Kishimoto H; Gochi A; Kimura T; Takahata T; Nonaka Y; Ninomiya M; Fujiwara T
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):937-43. PubMed ID: 23355040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.